Loading...
XSTO
ZZ B
Market cap690mUSD
May 30, Last price  
189.80SEK
1D
-2.16%
1Q
46.22%
Jan 2017
1,564.91%
IPO
2,888.98%
Name

Zinzino AB

Chart & Performance

D1W1MN
P/E
39.07
P/S
3.00
EPS
4.86
Div Yield, %
1.58%
Shrs. gr., 5y
2.41%
Rev. gr., 5y
25.42%
Revenues
2.21b
+31.71%
44,316,00063,925,00091,618,000177,164,000254,530,000357,730,000443,836,000492,310,000540,322,000585,577,000710,777,0001,074,448,0001,288,481,0001,356,008,0001,674,812,0002,205,917,000
Net income
169m
+3.32%
-1,607,000317,000820,0004,600,0009,027,00029,942,0008,195,0008,703,000-1,124,0006,359,00010,662,00064,477,00086,204,00067,697,000163,735,000169,169,000
CFO
309m
+25.58%
-2,639,0005,095,0002,054,0008,697,000-3,824,00049,162,00010,855,00010,253,00038,201,00020,435,00071,266,00097,312,000153,492,00042,857,000246,140,000309,110,000
Dividend
May 28, 20243 SEK/sh

Profile

Zinzino AB (publ), a direct sales company, engages in the sale of nutrition supplements, coffee, coffee machines, and accessories; The company offers balance control, immunity control, weight control, and skin care products. It also provides espresso machines, coffee, tea, and accessories. The company markets and sells its products in Sweden, Norway, Denmark, Finland, Iceland, Estonia, Lithuania, Latvia, Germany, Austria, Switzerland, the Netherlands, Poland, Hungary, Romania, Spain, Cyprus, France, Greece, Italy, United Kingdom, Czech Republic, Slovakia, the United States, Canada, Singapore, Malaysia, Taiwan, Thailand, Hong Kong, Australia, South Africa, and India. Zinzino AB (publ) was founded in 2005 and is headquartered in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong, Malaysia, and India.
IPO date
Sep 20, 2010
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,205,917
31.71%
1,674,812
23.51%
1,356,008
5.24%
Cost of revenue
1,473,440
1,370,582
1,174,521
Unusual Expense (Income)
NOPBT
732,477
304,230
181,487
NOPBT Margin
33.21%
18.17%
13.38%
Operating Taxes
49,937
46,004
20,689
Tax Rate
6.82%
15.12%
11.40%
NOPAT
682,540
258,226
160,798
Net income
169,169
3.32%
163,735
141.86%
67,697
-21.47%
Dividends
(102,923)
(59,256)
(67,405)
Dividend yield
3.29%
2.87%
7.60%
Proceeds from repurchase of equity
55,678
4,459
18,340
BB yield
-1.78%
-0.22%
-2.07%
Debt
Debt current
21,446
19,676
18,166
Long-term debt
70,684
95,560
86,767
Deferred revenue
Other long-term liabilities
30,323
27,257
26,536
Net debt
(370,920)
(206,000)
(58,256)
Cash flow
Cash from operating activities
309,110
246,140
42,857
CAPEX
(4,095)
(1,348)
(24,935)
Cash from investing activities
(98,670)
(11,918)
(35,425)
Cash from financing activities
(68,626)
(74,866)
(81,284)
FCF
691,695
255,895
145,863
Balance
Cash
463,050
321,236
161,880
Long term investments
1,309
Excess cash
352,754
237,495
95,389
Stockholders' equity
289,025
221,993
121,073
Invested Capital
173,507
130,440
121,547
ROIC
449.12%
204.95%
207.00%
ROCE
155.92%
85.50%
81.88%
EV
Common stock shares outstanding
36,993
34,613
34,308
Price
84.60
41.95%
59.60
130.56%
25.85
-54.65%
Market cap
3,129,610
51.71%
2,062,927
132.61%
886,858
-55.66%
EV
2,758,690
1,860,759
834,528
EBITDA
763,251
336,028
206,561
EV/EBITDA
3.61
5.54
4.04
Interest
3,885
2,784
Interest/NOPBT
1.28%
1.53%